All the news Showing 10 of 10 articles from: Compassionate accessGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Early Access to Medicines Scheme (EAMS) Granted to AbbVie’s Investigational Pan-genotypic Regimen for Chronic Hepatitis C in UK AbbVie press release / 10 May 2017 Is a Cheap Hepatitis C Cure About to Go Global? Motley Fool / 10 September 2014 NHS England agrees funding for life-saving hepatitis C drug NHS England (press release) / 17 April 2014 England: Patients with end-stage liver disease caused by hepatitis C to get new drug The Guardian / 17 April 2014 Sofosbuvir: Gilead must commit to compassionate use & expanded access EATG / 10 April 2014 European Medicines Agency advises on compassionate use of daclatasvir European Medicines Agency / 26 November 2013 European Medicines Agency advises on compassionate use of sofosbuvir European Medicines Agency / 26 October 2013 Sign-on letter to Gilead about sofosbuvir TRT-5 / 29 July 2013 Compassionate access to new hepatitis C drugs an "emergency" for European patients Keith Alcorn / 30 April 2013 European governments must move quickly to ensure that compassionate use arrangements are put into place to allow access to new hepatitis C drugs for people with cirrhosis, advocates and doctors said at ... Nucleotide Polymerase Inhibitors - The Search For A Safe Interferon Free Trial HCV New Drugs Research / 10 January 2013 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive